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ABSTRACT 
Objective: The aim of this study was to evaluate the effects of different intervals of the self-monitoring of blood glucose (SMBG) on 
glycemic control in a selected type 2 diabetic population. 
Methods: Type 2 diabetic patients with disease duration >1 year who were on insulin treatment for at least 6 months and were 
already applying SMBG were included in the study. A total of 118 patients were enrolled and classified into groups based on SMBG 
frequencies as once in a week, once in two weeks, once in a month and not at all. At the end of the 12 weeks glycemic control was 
assessed with measured blood glucose and A1c levels. 
Results: After 3 months of monitorization, A1c levels significantly decreased in group 1 (p<0.005) and group 2 patients (p<0.05) 
and no change or even an increase was observed in other groups. Reported hypoglycemic events were rare in all patients. 
Conclusion: SMBG is important for the achievement of glycemic goals and simplifying SMBG may help to overcome problems of 
compliance and cost. 
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TİP 2 DİYABETİK HASTALARDA KENDİ KENDİNE KAN GLUKOZ İZLEM SIKLIĞI 
GLİSEMİK KONTROLÜ ETKİLER Mİ? 
 
ÖZET 
Amaç: Kendi kendine kan şekeri ölçümü insülinle tedavi edilen tüm diyabetik hastalar için önerilmektedir. Her ne kadar tip 1 
diyabetik hastalar için standart takip programları belirlenmiş ise de tip 2 diyabetik hastalar için standart bir kan glukoz takip programı 
yoktur. Bu çalışmanın amacı tip 2 diyabetik hastalarda kendi kendine kan glukoz ölçüm sıklığının glisemik kontrol üzerine olan 
etkilerini değerlendirmektir. 
Yöntem: Bu çalışmaya kendi kendine kan şekeri ölçümü yapan insülin kullanan tip 2 diyabetik 118 hasta dahil edilmiştir. Hastalar 
kan şekeri ölçüm sıklıklarına göre haftada bir (n=49), onbeş günde bir (n=33), ayda bir (n=14) ve hiç ölçüm yapmayan (n=22) olarak 
gruplara ayrılmıştır. Hastalara ölçüm tekniği konusunda eğitim verildikten sonra kan şekeri ölçümlerini yaparak insülin dozlarını 
ayarlamaları istenmiştir. Hiç kan şekeri ölçümü yapmayan hastalardan 3 aylık dönemlerde açlık ve tokluk kan şekeri ölçümleri 
istenmiştir. 3 aylık takip dönemi sonunda hastalar kan şekerleri ve A1c düzeylerindeki değişim açısından tekrar değerlendirilmiştir. 
Bulgular: Hastaların demografik özellikleri, kullanmakta oldukları insülin tipleri ve dozları açısından farklı olmadığı görülmüştür. 
Bazal A1c düzeyleri tüm grıuplarda benzer bulunmuştur. Kendi kendine kan şekeri ölçümü yapan hastaların komplikasyon oranları 
daha düşüktür. Haftada bir ve onbeş günde bir kendi kendine kan şekeri ölçümü yapan hastaların 3. ay sonunda A1c düzeylerinde 
anlamlı bir düzelme görülürken (p<0,001 ve p=0,017) ayda bir ölçüm yapan ve hiç ölçüm yapmayan grupların A1c düzeylerinde 
değişim olmamıştır. 
Sonuç: İnsülin kullanan tip 2 diyabetik hastalarda kendi kendine kan glukoz ölçüm sıklığı arttıkça glisemik kontrol daha iyi 
sağlanabilmektedir. 
 




The American Diabetes Association (ADA) 
recommends the self -monitoring of blood glucose 
(SMBG) for all type 1 and type 2 diabetic patients 
treated with insulin1. SMBG improves the efficacy 
of treatment and provides better glycemic targets. 
SMBG also prevents hypoglycemic episodes and 
enables a better adjustment of medications in a 
better way. 
 
SMBG has been applied with different measuring 
intervals and different timings2,3. It is evident that 
SMBG provides better glycemic control compared 
to patients not measuring their blood glucose4. 
Furthermore, increasing sampling frequency 
increases the likelihood of better A1c levels5,6. On 
the other hand, only 39.1% of insulin-treated type 
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2 diabetic patients perform SMBG daily and 10% 
measure blood glucose two or more times per 
day7. This shows that there is an important 
compliance problem. Although ADA reinforces 
more efforts for appropriate use of SMBG, a 
change in strategy is needed to increase 
compliance. 
 
Data from most studies are based on daily SMBG 
in both type 1 and type 2 diabetic patients but the 
consequences of increasing the measuring 
intervals of SMBG is not known. The aim of this 
study is to evaluate the effects of different 
intervals of SMBG on glycemic control in a 




The study was designed as open and prospective 
trial with a follow-up period of 12 weeks. 
Subjects were recruited from the outpatient 
endocrinology clinic of Marmara University 
Hospital. The recruitment of patients was 
completed in three months. Type 2 diabetic 
patients with a disease duration >1 year who were 
on insulin treatment for at least 6 months and 
were already applying SMBG were included in 
the study. Patients who were unable to continue 
SMBG for any reason or who were on oral 
antidiabetic medications were excluded. Pregnant 
or lactating women, patients with any chronic 
illness, drug or alcohol abuse were also not 
included. The use of drugs interfering with 
glucose metabolism such as glucocorticoids was 
also a reason for exclusion. Patients were asked 
not to change their dietary habits during the study 
period. The study was approved by the Ethics 
Committee of Marmara University Medical 
School and written informed consent was given 
by all subjects participating in the study. 
 
A total of 118 patients were enrolled between 
November 2003 and January 2004. A one week 
run-in period was used for  the education  of 
patients  in  the  use of  blood  glucose  meters  
 
(Medisense Optium Sensor-Abbott Laboratories). 
Patients were instructed to measure their blood 
glucose as often as they could. They were then 
classified into groups based on SMBG frequencies 
as once a week, once in two weeks, once a month 
and not at all. They were requested to measure 
blood glucose four times a day, before each main 
meal and at bed time without changing meal 
intervals. Obtained values were recorded in a 
diary. Patients were seen every four weeks. At 
each visit, patients were checked for the correct 
use of blood glucose meters and the self 
regulation of blood glucose was discussed.  
Height, weight, body mass index were recorded at 
the beginning of the study and at each visit. A1c 
levels were tested at the beginning and at the end 
of 12 weeks. 
 
Data were analyzed using a SPSS program 
(version 11.0). Comparisons between groups were 
done using Mann-Whitney test. A p value less 
than 0.05 was considered significant. The results 




Patients measuring their blood glucose once in a 
week constitute group I, once in two weeks group 
II, once in a month group III, not at all group IV, 
respectively. The demographic characteristics of 
the study groups are shown in Table I. Mean age 
of the subjects in all groups was above 60 years. 
Patients in group 2 were younger than patients in 
group 4 (64±9 vs 70±10 years, p<0.05). Sixty one 
percent of the patients (n=72) were women. 
Disease duration in group 3 was longer than 
others (p<0.05). Mean duration of insulin use and 
mean insulin doses were similar. Microvascular 
complications were significantly less in group II 
patients and were found to be increased 
significantly in patients who did not monitor their 
blood glucose (p<0,001). 
 
 
Table1: Demographic characteristics of study patients 
 Group 1 Group II Group III Group IV 
Age (years) 64±9 62±10∗ 66±10 70±10 
Sex (M/F) 36/13 12/21 9/5 15/7 
Disease duration (years) 13±7∗ 9±6 15±7 10±7 
Duration of insulin use (years) 4±3 4±3 5±4 4±3 
Mean insulin dose (U/day) 43±23 44±23 49±20 48±20 
Rate of complications (%)     
Retinopathy 36.7 12.5† 57.1 54.5 
Nephropathy 36.7 21.8† 64.2 54.5 
Neuropathy 34.6 28.1† 64.2 45.4 
*p<0.05, †p<0.001. GroupI patients measuring blood glucose once in a week, Group II once in two weeks, Group III once in a 
month, Group IV not at all. 
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Table II: Change in glycemic parameters during study 
 Group I Group II Group III Group IV 
Rate of hypoglycemia (%)     
Basal  12* 6† 0 0† 
Week 12 2* 3† 0 4† 
A1c (%)     
Basal 7.3±1.4 7.4±1.3† 7.8±1.2 7.8±1.1 
Week 12 6.5±0.6 6.9±0.7† 6.8±1.3 6.8±1.6 
P<0.005, †p<0.05, Group I patients measuring blood glucose once in a week, Group II once in two weeks, Group III once in a month, 
Group IV not at all.  
 
Baseline A1c levels were above 7% in all groups, 
without a significant difference between groups. 
After 3 months of monitorization, A1c levels 
significantly decreased in group 1 (p<0.005) and 
group 2 patients (p<0.05) and no change or 
increase was observed in other groups. Changes in 
A1c levels were similar in group I and II (Table 
II). The reduction in A1c levels was more 
prominent in women than in men (p<0.05). A1c 
levels improved as patients’ education status 
increased (p<0.05). Patients who had had at least 
one microvascular complication had A1c levels 
higher than those who did not (p<0.05). On the 
other hand, A1c levels were improved by frequent 
monitorization even in these complicated patients 
(p<0.05). Reported hypoglycemic events were 
rare in all patients and were almost equal in each 
group. A significant decrease was observed in 





The results of this study confirm the importance 
of SMBG in insulin-treated type 2 diabetic 
patients. Glycemic control improves as frequency 
of monitorization increases. These results are in 
accordance with previous studies 2,3. 
 
SMBG is recommended for all type 1 and insulin 
using type 2 diabetic patients in the ADA annual 
revisions. It is stated that SMBG should be an 
integral component of diabetes therapy and should 
be included in the management plans 1. Most of 
the major clinical trials point out that tightness of 
glycemic control plays a central role in the 
prevention of both microvascular and 
macrovascular complications in type 1 and type 2 
diabetes mellitus 8,9. Most of these trials include 
and recommend SMBG as part of the treatment 
plan. Besides providing tight glycemic control, 
SMBG also allows patients to self monitor their 
response to treatment. Being a part of treatment 
can increase the compliance of patients. In 
addition, SMBG may help to prevent 
hypoglycemic episodes and allows management 
of treatment plans. 
The frequency and timing of SMBG change with 
the needs of the patients to achieve glycemic 
targets. ADA recommends 3 or more blood 
glucose measurements per day for type 1 and 
gestational diabetic patients 1. There is no optimal 
frequency of SMBG in type 2 diabetic patients. It 
is recommended that SMBG should be frequent 
enough to facilitate the achievement of 
appropriate glycemic control and prevent 
hypoglycemia 1. Most of the studies done with 
type 2 diabetic patients demonstrate that SMBG 
provides better achievement of glycemic targets. 
These studies suggest that the frequency of 
SMBG should be at least once daily and indicate 
that better glycemic control is achieved as the 
frequency of measurements increases. There is no 
data on the effect of less frequent measurements 
on glycemic control. This is the first study 
investigating the outcome of various sampling 
intervals and showing that sampling once in one 
or two weeks improves glycemic control in a short 
period of time. The results of this study are 
important and should be carefully interpreted. It 
does not deny the importance of more frequent 
monitorization. SMBG with more frequent 
intervals provide a better control but increasing 
the frequency may lead to poor compliance. Only 
10% of patients do the samplings two or more 
times per day irrespective of glycemic status 7. In 
our study, compliance was 100%. Another 
important problem is acquirement of test strips. 
Only 20% of type 1 diabetics and 17% of insulin 
treated type 2 diabetic patients obtain enough test 
strips to measure their blood glucose 3. This may 
be an important issue when state insurance 
reimburses only one test strip per day for insulin 
dependant type 2 diabetic patients. Considering 
the problem of compliance, measurement of blood 
glucose at least once in two weeks with four 
measurements per day would be a relevant 
message of this study. 
 
Limitations of this study are brief study duration, 
small sample size and having no group 
performing daily SMBG. Furthermore the results 
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cannot be extrapolated for a longer term. This 
study should be verified with future studies that 
take into account these limitations. 
 
In conclusion, SMBG is important for the 
achievement of glycemic goals and this can be 
attained by measuring blood glucose at least once 
in two weeks, with four measurements done on 
each day. Since poor compliance and failure to 
reimburse test strips may be an obstacle in 
reaching glycemic targets, simplifying SMBG 
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